February 6, 2024
A Japanese health ministry panel on February 5 gave the go-ahead to the filing of a public knowledge-based application for Gilead Sciences’ Truvada (emtricitabine + tenofovir disoproxil fumarate) for the prevention of HIV. The drug however failed to clinch health...read more